Showing results (451-460 of 474) with videos related to

Sort By:
Pageof 48
Scientific Reports|April 28, 2024
Surgical treatment improves overall survival of hepatocellular carcinoma with extrahepatic metastases after conversion therapy: a multicenter retrospective studyXiaoshi Zhang, Xiaodong Zhu, Jianhong Zhong, et al.
Cell Research|January 6, 2026
Sensing of DNA double-strand breaks by the NHEJ system stabilizes RORγt transcriptional activity and shapes Th17 pathogenicity in autoimmunityGuan-Yu Chen, Wen-Jie Zhu, Zhuang Li, et al.
Cancer Immunology Research|April 27, 2022
Combination Neoantigen-Based Dendritic Cell Vaccination and Adoptive T-Cell Transfer Induces Antitumor Responses Against Recurrence of Hepatocellular CarcinomaSui Peng, Shuling Chen, Wei Hu, et al.
Journal of Hepatology|March 20, 2024
FASN-mediated fatty acid biosynthesis remodels immune environment in Clonorchis sinensis infection-related intrahepatic cholangiocarcinomaLixia Xu, Ying Zhang, Zhilong Lin, et al.
NPJ Digital Medicine|August 2, 2025
AI enhanced diagnostic accuracy and workload reduction in hepatocellular carcinoma screeningRui-Fang Lu, Chao-Yin She, Dan-Ni He, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 4, 2018
Development and Validation of a Novel Signature to Predict Overall Survival in "Driver Gene-negative" Lung Adenocarcinoma (LUAD): Results of a Multicenter StudyYongmei Cui, Wenfeng Fang, Chaofeng Li, et al.
Nature Microbiology|January 3, 2025
Gut-liver translocation of pathogen Klebsiella pneumoniae promotes hepatocellular carcinoma in miceXueliang Wang, Yi Fang, Wei Liang, et al.
The Journal of Clinical Investigation|February 8, 2022
An Asia-specific variant of human IgG1 represses colorectal tumorigenesis by shaping the tumor microenvironmentBing Yang, Zhen Zhang, Xiangjun Chen, et al.
Cellular & Molecular Immunology|September 4, 2020
Cell cycle-related kinase reprograms the liver immune microenvironment to promote cancer metastasisXuezhen Zeng, Jingying Zhou, Zhewen Xiong, et al.
Liver Cancer|May 26, 2025
Comparison of Efficacy between Lenvatinib and Bevacizumab in Combination of Immune Checkpoint Inhibitor and Interventional Triple Therapy in Chinese Advanced Hepatocellular Carcinoma: The CLEAP 2302 StudyZhaolong Pan, Dongming Liu, Junbo Cao, et al.
Pageof 48